|
시장보고서
상품코드
2051122
특수 임상 검사 시장 : 유형별, 기술별, 서비스 제공업체별, 지역별Esoteric Testing Market, By Type, By Technology, By Service Provider, By Geography |
||||||
특수 임상 검사 시장은 2026년에 357억 8,000만 달러로 추정되고, 2033년까지 766억 6,000만 달러에 이를 전망입니다. 또한 2026-2033년 CAGR 11.5%를 기록할 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 357억 8,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 11.50% | 2033년 시장 규모 예측 : | 766억 6,000만 달러 |
최근 기술 및 의학연구의 발전으로 고도로 전문화된 진단검사의 개발이 가능해지면서 특수검사 분야가 큰 주목을 받고 있습니다. 특수 임상 검사란 일반적으로 시행되지 않고 전문 장비, 전문 지식 및 해석이 필요한 임상 검사를 말합니다. 이러한 검사는 희귀질환의 진단, 치료 효과 모니터링, 맞춤형 의료 솔루션 제공에 자주 활용되고 있습니다.
세계 특수 임상 검사 시장은 만성질환 유병률 증가, 유전자 검사 발전, 맞춤형 의료에 대한 수요 증가 등의 요인에 힘입어 괄목할 만한 성장을 거듭하고 있습니다. 특수 임상 검사는 질병의 조기 발견과 치료에 도움이 되는 유전자 변이, 바이오마커 및 기타 분자 이상을 식별하는 데 매우 중요한 역할을 합니다.
시장 역학:
세계 특수검사 시장은 주로 암, 심혈관질환, 자가면역질환 등 만성질환의 유병률 증가에 의해 주도되고 있습니다. 특수 임상 검사를 통해 의료진은 이러한 질환과 관련된 특정 유전자 변이 및 바이오마커를 식별할 수 있어 조기 진단 및 맞춤형 치료 계획을 수립할 수 있습니다. 또한, 정밀의료와 표적치료의 보급이 활발해지고 있는 것도 특수검사 수요를 더욱 부추기고 있습니다.
그러나 이 시장은 특수 임상 검사에 대한 높은 비용과 보험 환급 정책의 부재라는 문제에 직면해 있습니다. 특수 임상 검사는 전문 장비와 전문 지식이 필요하기 때문에 비용이 많이 드는 경우가 많습니다. 또한, 보험사에 의한 보상 범위가 제한적이라는 점이 특히 개발도상국에서 이러한 검사의 보급을 가로막고 있습니다.
이러한 도전에도 불구하고, 시장에는 몇 가지 성장 기회가 존재합니다. 예방의학에 대한 관심 증가와 질병 조기 발견의 이점에 대한 인식이 높아짐에 따라 특수 임상 검사에 대한 수요가 증가할 것으로 예측됩니다. 또한, 차세대 염기서열 분석, 분자진단 등의 기술 발전으로 특수 임상 검사의 정확도와 효율성이 향상되어 시장 확대를 위한 새로운 길이 열릴 수 있습니다.
본 조사의 주요 특징:
- 이 보고서는 각 부문의 잠재적 수익기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 에소테릭 테스트 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 난해한 검사 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 특수 임상 검사 시장 : 유형별, 2021년-2033년
제5장 특수 임상 검사 시장 : 기술별, 2021년-2033년
제6장 특수 임상 검사 시장 : 서비스 제공업체별, 2021년-2033년
제7장 특수 임상 검사 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.17Esoteric Testing Market is estimated to be valued at USD 35.78 Bn in 2026 and is expected to reach USD 76.66 Bn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 35.78 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 11.50% | 2033 Value Projection: | USD 76.66 Bn |
The field of esoteric testing has gained significant attention in recent years, as advancements in technology and medical research have allowed for the development of highly specialized diagnostic tests. Esoteric testing refers to laboratory tests that are not commonly performed and require specialized equipment, expertise, and interpretation. These tests are often used to diagnose rare diseases, monitor treatment effectiveness, and provide personalized healthcare solutions.
The global esoteric testing market is witnessing substantial growth, driven by factors such as the increasing prevalence of chronic diseases, advancements in genetic testing, and the growing demand for personalized medicine. Esoteric testing plays a crucial role in identifying genetic mutations, biomarkers, and other molecular abnormalities that can help in the early detection and treatment of diseases.
Market Dynamics:
The global esoteric testing market is primarily driven by the rising incidence of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders. Esoteric tests enable healthcare professionals to identify specific genetic mutations and biomarkers associated with these diseases, facilitating early diagnosis and personalized treatment plans. Moreover, the growing adoption of precision medicine and targeted therapies further fuels the demand for esoteric testing.
However, the market faces certain challenges, including the high cost of esoteric tests and the lack of reimbursement policies. Esoteric tests are often expensive due to the specialized equipment and expertise required for their execution. Additionally, the limited coverage by insurance providers hinders the widespread adoption of these tests, particularly in developing regions.
Despite these challenges, the market presents several opportunities for growth. The increasing focus on preventive healthcare and the rising awareness about the benefits of early disease detection are expected to drive the demand for esoteric testing. Furthermore, advancements in technology, such as next-generation sequencing and molecular diagnostics, are likely to enhance the accuracy and efficiency of esoteric tests, opening new avenues for market expansion.
Key Features of the Study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- Key companies covered as a part of this study include LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings, Myriad Genetics, Sonic Healthcare, Cardio Diagnostics Holdings, Inc, Veravas, BPGbio, Inc., Fulgent Genetics, Alveo Technologies, Inc., and S.R.L. Diagnostics
- Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global esoteric testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global esoteric testing market
Esoteric Testing Market Segmentation
- By Type (Revenue, USD Bn, 2021 - 2033)
- Endocrinology
- Oncology
- Molecular Diagnostics
- Neurology
- Immunology
- Genetic Testing
- Others
- By Technology (Revenue, USD Bn, 2021 - 2033)
- Mass Spectrometry
- Real Time PCR
- Flow Cytometry
- Chemiluminescence
- ELISA
- Radioimmunoassay
- Others
- By Service Provider (Revenue, USD Bn, 2021 - 2033)
- Independent & Reference Labs
- Hospital-based Labs
- Specialty Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top Companies in Esoteric Testing Market
- LabCorp
- Quest Diagnostics
- OPKO Health
- Miraca Holdings
- Myriad Genetics
- Sonic Healthcare
- Cardio Diagnostics Holdings, Inc
- Veravas
- BPGbio, Inc.
- Fulgent Genetics
- Alveo Technologies, Inc.
- S.R.L. Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Esoteric Testing, By Type
- Market Esoteric Testing, By Technology
- Market Esoteric Testing, By Service Provider
- Market Esoteric Testing, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising prevalence of chronic and infectious diseases
- Restraints
- High costs and inadequate reimbursements
- Opportunities
- Point-of-care esoteric testing
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Esoteric Testing Market, By Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Endocrinology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Molecular Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
5. Esoteric Testing Market, By Technology, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Mass Spectrometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Real Time PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Chemiluminescence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Radioimmunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
6. Esoteric Testing Market, By Service Provider, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Independent & Reference Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Hospital-based Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
7. Esoteric Testing Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2021 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Provider, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- LabCorp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OPKO Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Miraca Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sonic Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cardio Diagnostics Holdings, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Veravas
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BPGbio, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fulgent Genetics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Alveo Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- R.L. Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
